DG also acts as a natural NLRP3 inhibitor, exerting therapeutic effects on NAFLD through the NLRP3 inflammasome-dependent signaling pathway [87]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.